Your search returned 75 studies. (Get alerts for new studies):
- Storage of Bile From Routine Procedures to Study Risk Factors
Conditions: Gallbladder Cancer - Cholangiocarcinoma - Biliary Tract Cancer
1 Location available
- Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Conditions: Bladder Cancer - Hemostasis
1 Location available
- Familial and Atypical Urothelial Cancer Registry
Conditions: Urothelial Cancer - Renal Pelvis Cancer - Ureter Cancer - Bladder Cancer
5 Locations available
- Tesetaxel for Previously Treated Patients With Bladder Cancer
Conditions: Carcinoma, Transitional Cell
2 Locations available
- Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer
Conditions: Biliary Tract Cancer - Gallbladder Cancer
2 Locations available
- Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
Conditions: Recurrent Bladder Cancer - Stage III Bladder Cancer - Stage IV Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Study of Individuals and Families at High Risk for Cancer
Conditions: Bladder Cancer - Brain and Central Nervous System Tumors - Chordoma - Lung Cancer - Non-melanomatous Skin Cancer - Retinoblastoma - Sarcoma
2 Locations available
- Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
Conditions: Bladder Cancer
6 Locations available
- Bladder Cancer Imaging Study-OCT Imaging to Stage Bladder Tumors
Conditions: Bladder Cancer
1 Location available
- 3 Tesla MRI in Patients With Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Conditions: Bladder Cancer
15 Locations available
- Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy
Conditions: Urothelial Carcinoma - Bladder Cancer
1 Location available
- Randomized Trial Comparing Robotic and Open Radical Cystectomy
Conditions: Bladder Cancer
1 Location available
- Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit
Conditions: Bladder Cancer
2 Locations available
- Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Periampullary Adenocarcinoma
7 Locations available
- RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder
Conditions: Bladder Cancer
1 Location available
- Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
Conditions: Bladder Cancer
1 Location available
- Imaging Study for FdCyd and THU Cancer Treatment
Conditions: Head and Neck Neoplasms - Lung Neoplasms - Urinary Bladder Neoplasms - Breast Neoplasms
1 Location available
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma
Conditions: Bladder Cancer
1 Location available
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Lung Cancer - Melanoma - Non-Hodgkin's Lymphoma - Uterine Cancer - CORPUS UTERI,ENDOMETRIUM - LUNG - OVARY
1 Location available
- Use of Multiphoton Microscopy in the Diagnosis of Cancer
Conditions: Bladder Cancer - Prostate Cancer
1 Location available
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Conditions: Bladder Cancer - Renal Pelvis Cancer - Ureter Cancer
1 Location available
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Bladder Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter
5 Locations available
- Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
Conditions: Solid Tumors - Bladder Cancer
1 Location available
- Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
Conditions: Superficial Bladder Cancer
1 Location available
- Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
Conditions: Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder
1 Location available
- Molecular Analysis Of Bladder Cancer
Conditions: Bladder Cancer - Bladder Neoplasms
1 Location available
- Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer
Conditions: Bladder Cancer - Cancer - Bladder Neoplasms - Urinary Bladder Cancer
1 Location available
- Duke Urology Database and Specimen Bank
Conditions: Urologic - Prostate Cancer - Bladder Cancer - Erectile Dysfunction - Incontinence
1 Location available
- A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
Conditions: Cholangiocarcinoma
3 Locations available
- Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Conditions: Bladder Cancer - Bladder (Urothelial, Transitional Cell) Cancer - Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) - Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) - Bladder (Urothelial, Transitional Ce
2 Locations available
- PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Conditions: Cholangiocarcinoma - Hepatobiliary Neoplasm - Liver Cancer - Bile Duct Cancer - Cancer of Gallbladder
1 Location available
- Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
Conditions: Bladder Cancer
7 Locations available
- Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
Conditions: Colorectal Cancer - Esophageal Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Gastrointestinal Complications - Liver Cancer - Pancreatic Cancer - Radiation Toxicity
1 Location available
- Tamoxifen in Treating Patients With Metastatic Bladder Cancer That Did Not Respond to Previous Chemotherapy
Conditions: Bladder Cancer
4 Locations available
- Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
Conditions: Bladder Cancer
3 Locations available
- Permission to Collect Blood Over Time for Research
Conditions: Pancreatic Cancer - Gastrointestinal Neoplasms - Colon Rectal Cancer Adenocarcinoma - Esophageal Cancer - Gall Bladder Cancer - Gastric (Stomach) Cancer - Gastrooesophageal Cancer - Gastrointestinal Stromal Tumor (GIST) - Hepatobiliary Neoplasm - Liver Ca
1 Location available
- Screening for Bladder Cancer
Conditions: Bladder Cancer
2 Locations available
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma - Biliary Tract Cancer - Gallbladder Cancer
1 Location available
- Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients
Conditions: Bladder Cancer
1 Location available
- Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
Conditions: Bladder Cancer
5 Locations available
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
2 Locations available
- Phase IB Intravesical Administration of SCH 721015
Conditions: Bladder Cancer
1 Location available
- Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small
Conditions: Anemia - Carcinoma, Non-Small-Cell Lung - Carcinoma, Small-Cell Lung - Bladder Cancer - Cancer of Head and Neck - Uterine Cervical Cancer
39 Locations available
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder - Urethra Cancer - Ureter Cancer - Malignant Tumor of Renal Pelvis
7 Locations available
- A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
Conditions: Urologic Neoplasms - Metastatic Bladder Cancer - Urinary Tract Neoplasms
12 Locations available
- Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
Conditions: Bladder Cancer
1 Location available
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
236 Locations available
- Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Conditions: Breast Cancer - Colon Cancer - Bladder Cancer
2 Locations available
- Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
Conditions: Bladder Cancer
28 Locations available
- Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer
Conditions: Bladder Cancer
5 Locations available
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Bladder Cancer
65 Locations available
- E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Bladder Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
24 Locations available
- Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Conditions: Bladder Cancer
72 Locations available
- Cognitive and Behavioral Therapy or Standard Care in Patients With Advanced Gastrointestinal Cancer or Lung Cancer
Conditions: Anxiety Disorder - Colorectal Cancer - Depression - Esophageal Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Psychosocial Effects of Cancer and Its Treatment
1 Location available
- Quality of Life in Patients With Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Genetic Susceptibility to Bladder Cancer
Conditions: Bladder Cancer - Healthy
2 Locations available
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
496 Locations available
- Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duoden
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Pancreatic Cancer - Periampullary Adenocarcinoma - Small Intestine Cancer
2 Locations available
- Dose Dense MVAC for Muscle Invasive Bladder Cancer
Conditions: Muscle Invasive Bladder Cancer - High Risk Urothelial Carcinoma of the Upper Urinary Tracts
2 Locations available
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial
Conditions: Bladder Cancer Requiring Cystectomy
13 Locations available
- A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers
Conditions: Non-Small Cell Lung Neoplasms - Prostate Neoplasms - Bladder Neoplasms - Ovarian Neoplasms - Breast Neoplasms
1 Location available
- Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer
5 Locations available
- The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer - Colorectal Cancer - Endometrial Cancer - Kidney Cancer - Skin Cancer - Uterus Cancer
1 Location available
- Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer
1 Location available
- Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes
Conditions: Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder
1 Location available
- A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies
Conditions: Bladder Cancer - Skin Cancers - Bladder (Urothelial, Transitional Cell) Cancer - Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
1 Location available
- Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer - Stage 0 Bladder Cancer - Stage I Bladder Cancer - Stage II Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
Conditions: Bladder Cancer
12 Locations available
- Gemcitabine, Cisplatin, and Lenalidomide for Bladder Cancer
Conditions: Ureteral Neoplasms - Urinary Bladder Neoplasms - Urethral Neoplasms
1 Location available
- Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer
Conditions: Urothelial Carcinoma of the Bladder
1 Location available
|